American Association for the Study of Liver Diseases and the Japan Society of Hepatology Joint Session: Evolving Strategies in Liver Cancer Management—Prevention, East Versus West
Nov
2026
Description
Jointly presented by the American Association for the Study of Liver Diseases and the Japan Society of Hepatology, this progam is the second of 2 sessions with the shared goal of reviewing evolving strategies in liver cancer management in Eastern and Western regions. The first session, presented at Japan DDW 2026 in Kobe, Japan, focused on liver cancer treatment. This second session focuses on the prevention of liver cancer in persons with viral and metabolic liver diseases.
Presentations
5:00 PM
- 5:20 PM
Convention Center - Bluebird Ballroom 2GH
Hepatitis C Virus Control for Prevention of Liver Cancer in the United States
Anjana Pillai, MD, FAASLD | Presenter
5:20 PM
- 5:40 PM
Convention Center - Bluebird Ballroom 2GH
Multidisciplinary Preventive Interventions for Viral Liver Cancer in Japan
Yasuhiro Asahina, M.D., Ph.D. | Moderator
5:40 PM
- 6:00 PM
Convention Center - Bluebird Ballroom 2GH
Emerging Therapies for Metabolic Diseases as Prevention of Steatotic Liver Disease–Related Liver Cancer in the United States
Daniel Q Huang | Presenter
6:00 PM
- 6:20 PM
Convention Center - Bluebird Ballroom 2GH
Physical and Dietary Interventions for Prevention of Liver Cancer From Metabolic Etiologies in Japan
Ryosuke Tateishi, MD, PhD, FAASLD | Presenter
